This inventor holds 1 USPTO granted patent. Top assignee: Hong Kong Baptist University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Neurodegenerative Disease Treatment by Sravan G S Sreenivasamurthy
Introduction
Sravan G S Sreenivasamurthy is an innovative inventor based in Hong Kong, CN, who has made significant contributions to the field of neurodegenerative diseases. His unique approach to herbal composition has positioned him as a notable figure in research and development aimed at tackling these complex medical issues.
Latest Patents
Sravan holds one patent titled "Uses and Development of Neurodefend for Treating Neurodegenerative Diseases." This patent introduces a herbal composition that demonstrates potent therapeutic effects by effectively targeting both amyloid-β (Aβ) and tau-associated neurofibrillary tangles (NFTs). His work showcases a promising avenue for the treatment of conditions such as Alzheimer’s disease.
Career Highlights
Currently, Sravan is associated with Hong Kong Baptist University, where he continues to explore innovative treatments and solutions for neurodegenerative conditions. His dedication to research and development in the field exemplifies his commitment to improving patient outcomes and advancing scientific knowledge.
Collaborations
Throughout his career, Sravan has collaborated with talented colleagues, including Min Li and Ashok Iyaswamy. Their collective efforts in research contribute to a broader understanding of neurodegenerative diseases and the development of effective therapeutic strategies.
Conclusion
Sravan G S Sreenivasamurthy's innovative work in the development of Neurodefend not only demonstrates his capabilities as an inventor but also highlights a significant stride in the fight against neurodegenerative diseases. His contributions are invaluable to the scientific community and hold the potential to impact many lives positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
